NO912805L - Fremgangsmaate for fremstilling av pyrazolopyridin-forbindelser. - Google Patents

Fremgangsmaate for fremstilling av pyrazolopyridin-forbindelser.

Info

Publication number: NO912805L
Authority: NO; Norway
Prior art keywords: alkyl; heterocyclic group; alkylamino; suitable substituent; preparing
Prior art date: 1990-07-18

Application number

NO91912805A

Other languages

English (en)

Other versions

NO178697B (no

NO912805D0 (no

NO178697C (no

Inventor

Youichi Shiokawa

Atsushi Akahane

Hirohito Katayama

Takafumi Mitsunaga

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-07-18

Filing date

1991-07-17

Publication date

1992-01-20

1991-07-17 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1991-07-17 Publication of NO912805D0 publication Critical patent/NO912805D0/no

1992-01-20 Publication of NO912805L publication Critical patent/NO912805L/no

1996-02-05 Publication of NO178697B publication Critical patent/NO178697B/no

1996-05-15 Publication of NO178697C publication Critical patent/NO178697C/no

Links

150000005229 pyrazolopyridines Chemical class 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 11
125000000623 heterocyclic group Chemical group 0.000 abstract 5
125000003282 alkyl amino group Chemical group 0.000 abstract 4
125000001424 substituent group Chemical group 0.000 abstract 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
125000004093 cyano group Chemical group *C#N 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000004104 aryloxy group Chemical group 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
-1 pyrazolopyridine compound Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

NO912805A 1990-07-18 1991-07-17 Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrazolopyridin-forbindelser NO178697C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909015764A GB9015764D0 (en)	1990-07-18	1990-07-18	Pyrazolopyridine compound and processes for preparation thereof

Publications (4)

Publication Number	Publication Date
NO912805D0 NO912805D0 (no)	1991-07-17
NO912805L true NO912805L (no)	1992-01-20
NO178697B NO178697B (no)	1996-02-05
NO178697C NO178697C (no)	1996-05-15

Family

ID=10679258

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO912805A NO178697C (no)	1990-07-18	1991-07-17	Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrazolopyridin-forbindelser

Country Status (20)

Country	Link
US (1)	US5204346A (no)
EP (1)	EP0467248B1 (no)
JP (1)	JP3123562B2 (no)
KR (1)	KR100219957B1 (no)
CN (1)	CN1042730C (no)
AT (1)	ATE172731T1 (no)
AU (1)	AU651353B2 (no)
CA (1)	CA2047283C (no)
DE (1)	DE69130412T2 (no)
DK (1)	DK0467248T3 (no)
ES (1)	ES2121760T3 (no)
FI (1)	FI96688C (no)
GB (1)	GB9015764D0 (no)
HU (1)	HU218666B (no)
IE (1)	IE912427A1 (no)
IL (1)	IL98872A (no)
NO (1)	NO178697C (no)
PH (1)	PH30486A (no)
PT (1)	PT98358B (no)
ZA (1)	ZA915376B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5338743A (en) *	1988-06-06	1994-08-16	Fujisawa Pharmaceutical Co., Ltd.	New use of the adenosine antagonist
DE69232323T2 (de) *	1991-01-29	2002-08-08	Fujisawa Pharmaceutical Co., Ltd.	Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera
DE4237656A1 (de) *	1992-06-13	1993-12-16	Merck Patent Gmbh	Benzimidazolderivate
AU694157B2 (en) *	1993-12-29	1998-07-16	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine adenosine antagonists
WO1997040047A1 (en) *	1996-04-25	1997-10-30	Fujisawa Pharmaceutical Co., Ltd.	Preventives and remedies for ischemic intestinal lesion and ileus
AUPO111096A0 (en) *	1996-07-18	1996-08-08	Fujisawa Pharmaceutical Co., Ltd.	New compound
AU733034B2 (en) *	1996-07-18	2001-05-03	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
KR100517397B1 (ko) *	1996-10-04	2005-09-29	교린 세이야꾸 가부시키 가이샤	피라졸로피리딜피리다지논 유도체 및 이를 포함하는 기관지 확장제
EP0972525A4 (en) *	1997-03-18	2000-11-29	Fujisawa Pharmaceutical Co	PREVENTIVE AND HEALING AGENTS AGAINST HYPERPHOSPHATEMIA
ES2256817T3 (es)	1997-09-05	2006-07-16	Glaxo Group Limited	Composiciones farmaceuticas que comprenden derivados de 2,3-diaril-pirazolo(1,5-b)piridazina.
US6060481A (en) *	1998-05-28	2000-05-09	The Penn State Research Foundation	Method for improving insulin sensitivity using an adenosine receptor antagonist
CA2333947C (en) *	1998-06-01	2010-09-21	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compounds as adenosine a1 antagonist for male sterility
WO1999067239A1 (en) *	1998-06-22	1999-12-29	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compounds and medicinal uses thereof
HUP0104204A3 (en)	1998-11-03	2002-06-28	Glaxo Group Ltd	Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof
US6498166B1 (en)	1999-02-27	2002-12-24	Smithkline Beecham Corporation	Pyrazolopyridines
US20040152659A1 (en) *	1999-05-12	2004-08-05	Fujisawa Pharmaceutical Co. Ltd.	Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
AUPQ441499A0 (en) *	1999-12-02	2000-01-06	Fujisawa Pharmaceutical Co., Ltd.	Novel compound
GB9930358D0 (en)	1999-12-22	2000-02-09	Glaxo Group Ltd	Process for the preparation of chemical compounds
PE20020506A1 (es)	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
AUPQ969800A0 (en) *	2000-08-28	2000-09-21	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyridine compound and pharmaceutical use thereof
DE60112330T2 (de) *	2000-12-15	2006-04-13	Glaxo Group Ltd., Greenford	Pyrazolopyridinderivate
EP1341788B1 (en)	2000-12-15	2005-08-10	Glaxo Group Limited	Pyrazolopyridines
EP1366048B1 (en) *	2001-03-08	2004-08-25	SmithKline Beecham Corporation	Pyrazolopyridine derivatives
US7034030B2 (en)	2001-03-30	2006-04-25	Smithkline Beecham Corporation	Pyralopyridines, process for their preparation and use as therapeutic compounds
WO2002078701A1 (en) *	2001-03-30	2002-10-10	Smithkline Beecham Corporation	Use of pyrazolopyridines as therapeutic compounds
JP4219171B2 (ja) *	2001-04-10	2009-02-04	スミスクラインビーチャムコーポレーション	抗ウイルス性ピラゾロピリジン化合物
US6756498B2 (en)	2001-04-27	2004-06-29	Smithkline Beecham Corporation	Process for the preparation of chemical compounds
ATE296826T1 (de)	2001-04-27	2005-06-15	Smithkline Beecham Corp	Pyrazolo(1,5)pyridinderivate
AUPR548601A0 (en) *	2001-06-06	2001-06-28	Fujisawa Pharmaceutical Co., Ltd.	Pyrazolopyrazinecompound and pharmaceutical use thereof
WO2003000689A1 (en) *	2001-06-21	2003-01-03	Smithkline Beecham Corporation	Imidazo`1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections
DE60220525T2 (de) *	2001-09-07	2008-02-07	Smithkline Beecham Corp.	Pyrazolo-pyridine für die behandlung von herpes-ansteckungen
ES2262893T3 (es) *	2001-10-05	2006-12-01	Smithkline Beecham Corporation	Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes.
JP2005516916A (ja)	2001-12-11	2005-06-09	スミスクラインビーチャムコーポレーション	抗ヘルペス薬としてのピラゾロ−ピリジン誘導体
US7153863B2 (en) *	2002-10-03	2006-12-26	Smithkline Beecham Corporation	Therapeutic compounds based on pyrazolopyridline derivatives
UA103319C2 (en)	2008-05-06	2013-10-10	Глаксосмитклайн Ллк	Thiazole- and oxazole-benzene sulfonamide compounds
CA2732165A1 (en) *	2008-08-04	2010-02-11	Astrazeneca Ab	Therapeutic agents 414
CN113939295B (zh) *	2019-03-20	2025-05-16	金翅雀生物公司	哒嗪酮及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4024255A (en) *	1973-04-05	1977-05-17	Allen & Hanburys Limited	Tetrazole containing naphthyridine-3-carboxamides
US4304777A (en) *	1979-08-30	1981-12-08	Sterling Drug Inc.	6-(Pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics
JPS5826802A (ja) *	1981-08-10	1983-02-17	Sankyo Co Ltd	農園芸用殺菌剤
US4666902A (en) *	1983-06-20	1987-05-19	Cassella Aktiengesellschaft	Tetrahydropyridazinone derivatives, processes for their preparation and their use
HU195645B (en) *	1985-10-30	1988-06-28	Gyogyszerkutato Intezet	Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same
US4925849A (en) *	1987-06-15	1990-05-15	Fujisawa Pharmaceutical Company, Ltd.	Pharmaceutically useful pyrazolopyridines
JPH0710865B2 (ja) *	1987-06-26	1995-02-08	日本バイエルアグロケム株式会社	ニトロ置換ヘテロ環式化合物及び殺虫剤
GB8901423D0 (en) *	1989-01-23	1989-03-15	Fujisawa Pharmaceutical Co	Pyrazolopyridine compound and processes for preparation thereof

1990
- 1990-07-18 GB GB909015764A patent/GB9015764D0/en active Pending
1991
- 1991-07-09 PH PH42760A patent/PH30486A/en unknown
- 1991-07-10 ZA ZA915376A patent/ZA915376B/xx unknown
- 1991-07-11 IE IE242791A patent/IE912427A1/en not_active Application Discontinuation
- 1991-07-13 ES ES91111715T patent/ES2121760T3/es not_active Expired - Lifetime
- 1991-07-13 EP EP91111715A patent/EP0467248B1/en not_active Expired - Lifetime
- 1991-07-13 DK DK91111715T patent/DK0467248T3/da active
- 1991-07-13 AT AT91111715T patent/ATE172731T1/de not_active IP Right Cessation
- 1991-07-13 DE DE69130412T patent/DE69130412T2/de not_active Expired - Fee Related
- 1991-07-15 US US07/729,688 patent/US5204346A/en not_active Expired - Fee Related
- 1991-07-16 AU AU80468/91A patent/AU651353B2/en not_active Ceased
- 1991-07-16 JP JP03268125A patent/JP3123562B2/ja not_active Expired - Fee Related
- 1991-07-17 PT PT98358A patent/PT98358B/pt not_active IP Right Cessation
- 1991-07-17 FI FI913446A patent/FI96688C/fi active
- 1991-07-17 IL IL9887291A patent/IL98872A/en not_active IP Right Cessation
- 1991-07-17 CA CA002047283A patent/CA2047283C/en not_active Expired - Fee Related
- 1991-07-17 NO NO912805A patent/NO178697C/no unknown
- 1991-07-17 CN CN91105592A patent/CN1042730C/zh not_active Expired - Fee Related
- 1991-07-17 HU HU397/91A patent/HU218666B/hu not_active IP Right Cessation
- 1991-07-18 KR KR1019910012195A patent/KR100219957B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
GB9015764D0 (en)	1990-09-05
DE69130412T2 (de)	1999-04-22
PH30486A (en)	1997-05-28
DK0467248T3 (da)	1999-07-05
KR100219957B1 (ko)	1999-09-01
NO178697B (no)	1996-02-05
KR920002603A (ko)	1992-02-28
EP0467248A3 (en)	1992-03-11
IE912427A1 (en)	1992-01-29
ES2121760T3 (es)	1998-12-16
CN1042730C (zh)	1999-03-31
FI913446A0 (fi)	1991-07-17
FI913446L (fi)	1992-01-19
FI96688B (fi)	1996-04-30
US5204346A (en)	1993-04-20
AU651353B2 (en)	1994-07-21
DE69130412D1 (de)	1998-12-03
HUT58735A (en)	1992-03-30
NO912805D0 (no)	1991-07-17
FI96688C (fi)	1996-08-12
IL98872A (en)	1996-12-05
PT98358B (pt)	1999-01-29
EP0467248B1 (en)	1998-10-28
HU218666B (hu)	2000-10-28
JP3123562B2 (ja)	2001-01-15
CA2047283C (en)	2002-07-02
ZA915376B (en)	1992-04-29
CA2047283A1 (en)	1992-01-19
IL98872A0 (en)	1992-07-15
AU8046891A (en)	1992-01-23
CN1059143A (zh)	1992-03-04
HU912397D0 (en)	1991-12-30
EP0467248A2 (en)	1992-01-22
NO178697C (no)	1996-05-15
JPH04253978A (ja)	1992-09-09
ATE172731T1 (de)	1998-11-15
PT98358A (pt)	1992-05-29

Publication	Publication Date	Title
NO912805L (no)	1992-01-20	Fremgangsmaate for fremstilling av pyrazolopyridin-forbindelser.
FI890689A0 (fi)	1989-02-14	3-alkenyl-1-azabicyklo-/3.2.0/ -hept-2-en-2-karboxylsyrafoereningar.
IL93050A0 (en)	1990-11-05	Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL107426A0 (en)	1994-01-25	Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
NO882608D0 (no)	1988-06-14	Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyrideirer.
ATE107306T1 (de)	1994-07-15	3-pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en- 2-carbonsäure-verbindungen.
IL101544A0 (en)	1992-12-30	Pyrazolopyridine derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
FI860878A0 (fi)	1986-03-03	Aminosyraderivat och foerfarande foer deras framstaellning.
HUT56089A (en)	1991-07-29	Process for producing quinazoline derivatives and pharmaceutical compositions containing them
ES2092470T3 (es)	1996-12-01	Derivados de pirrolidina.
ES2061579T3 (es)	1994-12-16	Compuestos cefem y procedimientos para su preparacion.